The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution
- 1 December 2005
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (6) , 1601-1610.e2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1,465 consecutive patients undergoing complete resectionThe Annals of Thoracic Surgery, 2004
- Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobeThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Induction chemotherapy before surgery for early-stage lung cancer: A novel approachThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Results of surgical resection in patients with N2 non-small cell lung cancerThe Annals of Thoracic Surgery, 1994
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992
- Aggressive surgical intervention in N2 non-small cell cancer of the lungThe Annals of Thoracic Surgery, 1991
- Significance of Metastatic Disease in Subaortic Lymph NodesThe Annals of Thoracic Surgery, 1987
- Effects of Postoperative Mediastinal Radiation on Completely Resected Stage II and Stage III Epidermoid Cancer of the LungNew England Journal of Medicine, 1986